South Australian scleroderma register: Analysis of deceased patients

Pathology

Volumn 30, Issue 4, 1998, Pages 386-390

  Bond, Colin ^a   Pile, Kevin D ^b   Mcneil, Julian D ^c   Ahern, Michael J ^d   Smith, Malcolm D ^d   Cleland, Leslie G ^a   Roberts Thomson, Peter J ^d  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c MODBURY HOSPITAL   (Australia)

^d FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Epidemiology; Mortality; Outcome; Progressive systemic sclerosis; Scleroderma

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY;

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER; CARDIOVASCULAR DISEASE; CENTROMERE; CLINICAL FEATURE; DEMOGRAPHY; DISEASE DURATION; FEMALE; GENDER; HEART RIGHT VENTRICLE FAILURE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOLOGY; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SCLERODERMA; SEROLOGY; SURVIVAL RATE; SYSTEMIC SCLEROSIS;

EID: 0031771266     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313029800169676     Document Type: Article

References (12)

1. LeRoy EC, Black C, Fleischmajer R, Jahlonska S, Krieg T, Medsger TA. et al. Editorial. Scleroderma: classification, subset and pathogenesis. J Rheumatol 1988; 15: 202-5.
2. Reveille JD, Durban E, MacLeod MJ, Goldstein R, Moreda R, Altman RD. et al. Association of amino acid sequences in the HLA-DQB1 first domain with the anti-topoisomerase I autoantibody response in scleroderma (progressive system sclerosis). J Clin Invest 1992; 90: 973-80.
3. Kuwana M, Kaburaki J, Okano Y, Inoko H, Tsuji K. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J Clin Invest 1993; 92: 1296-301.
4. Chandran G, Smith MD, Ahern MJ, Roberts-Thomson PJ. A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy. Aust NZ J Med 1995; 25: 688-94.
5. Chandran G, Simmons L, Cheng G, Yaaka H, Nikoloutsopoulos T, Roberts-Thomson PJ. The abnormalities of nailfold capillaries in scleroderma as assessed by video image analysis and photomicroscopy. Asian Pacific J Immunol Allergy 1996; 14: 81-5.
6. Englert HJ. The epidemiology of scleroderma in Sydney, 1974-1988: a comparative study. Thesis for Doctor of Philosophy, Department of Medicine, University of Sydney, 1993.
7. Masi AT, Rodnan GP, Medsger TA Jr, Altman RD, D'Angelo WA, Fries JF, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1983; 23: 581-90.
8. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457-81.
9. Barnett AJ. Scleroderma (progressive systemic sclerosis): Progress and course based on a personal series of 118 cases. Med J Aust 1978; 2: 129-34.
10. Barnett AJ, Miller MH, Littlejohn GO. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a single cutaneous classification in the early stages of the disease. J Rheumatol 1988; 15: 276-83.
11. Wallman LL, Penny R, Williumson DJ. Pulmonary vascular aspects of systemic sclerosis. Aust NZ J Med 1996; 26: 150-3.
12. Youssef P, Englert H, Bertouch J. Large vessel occlusive disease associated with CREST syndrome and scleroderma. Ann Rheum Dis 1993; 52: 464-6.